Latest Breaking News On - ஹ்ஸீ வேந்‌ரைட் இணை - Page 6 : comparemela.com

Intec Closes Merger with Decoy Biosystems USA - English Changes Corporate Name to Indaptus Therapeutics to Reflect Clinical Focus News provided by Share this article Share this article NEW YORK, Aug. 3, 2021 /PRNewswire/ Indaptus Therapeutics, Inc. (Nasdaq: INDP) ( Indaptus or the Company, and formerly, Intec Parent, Inc.) today announced the closing of its previously announced merger with Decoy Biosystems, Inc. ( Decoy ) and the completion of a $30 million private placement in accordance with the merger agreement. In addition, the Company announced a corporate name change to Indaptus Therapeutics, as it better reflects the Company s therapeutic focus. Indaptus is expected to begin trading on the Nasdaq Capital Market at the open of trading on August 4, 2021, under the ticker symbol INDP and a new CUSIP number (45339J 105). The previous ticker symbol was NTEC (Nasdaq: NTEC). The Company will have a new website address: www.indaptusrx.com.

Jeffrey mecklerAnthonyj maddalunaHoonmo leeHila karahWintec pharmaRoger pomerantzBrian ocallaghanMichaelj newmanNir sassiWalt linscottJeffreya mecklerMichael newmanWilliamb hayesIntec parent incIndaptus therapeutics incPrnewswire indaptus therapeutics inc